COVID-19 (inactivated and mRNA) vaccine and humoral response in people with multiple sclerosis: Chilean cohort

被引：0
|
作者：
Galleguillos, L. [1 ]
Pallauta, K. [2 ]
Jerez, M. E. [2 ]
机构：
[1] Clin Alemana Neurol & Psiquiat, Santiago, Chile
[2] Univ Los Andes, Neurol, Santiago, Chile
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P683
引用
收藏
页码：581 / 582
页数：2
相关论文
共 50 条
  • [21] COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
    Francesca Proietti
    Doriana Landi
    Marta Ponzano
    Gaia Cola
    Giovanni Di Mauro
    Giorgia Mataluni
    Carolina Gabri Nicoletti
    Giuseppe Curcio
    Girolama Alessandra Marfia
    Neurological Sciences, 2023, 44 : 803 - 808
  • [22] Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
    Achiron, Anat
    Mandel, Mathilda
    Dreyer-Alster, Sapir
    Harari, Gil
    Magalashvili, David
    Sonis, Polina
    Dolev, Mark
    Menascu, Shay
    Flechter, Shlomo
    Falb, Rina
    Gurevich, Michael
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [23] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
    Toljan, K.
    Amin, M.
    Kunchok, A.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 86 - 87
  • [24] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
    Toljan, Karlo
    Amin, Moein
    Kunchok, Amy
    Ontaneda, Daniel
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
  • [25] Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies
    Mori, Akio
    Onozawa, Masahiro
    Tsukamoto, Shihori
    Ishio, Takashi
    Yokoyama, Emi
    Izumiyama, Koh
    Saito, Makoto
    Muraki, Haruna
    Morioka, Masanobu
    Teshima, Takanori
    Kondo, Takeshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (06) : 691 - 696
  • [26] Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia
    Mori, Akio
    Onozawa, Masahiro
    Kobayashi, Mirei
    Tsukamoto, Shihori
    Senjo, Hajime
    Ishio, Takashi
    Yokoyama, Emi
    Izumiyama, Koh
    Saito, Makoto
    Muraki, Haruna
    Morioka, Masanobu
    Teshima, Takanori
    Kondo, Takeshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 717 - 721
  • [27] mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series
    Larkin, Howard D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (23): : 2280 - 2280
  • [28] Humoral response to BNT162b2-COVID-19 or CoronaVac vaccine against COVID-19 in people with multiple sclerosis patients treated with high efficacy therapies
    Galleguillos, L.
    Alonso, R.
    Kagi, M.
    Hernandez, M.
    Diaz, V.
    Pallauta, K.
    Jerez, M. E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 792 - 792
  • [29] Humoral response to COVID-19 variants in people with Multiple Sclerosis: Impact of Anti-CD20 Therapy
    Shawe-Taylor, Marianne
    Greenwood, David
    He, Anna
    Hobbs, Agnieszka
    Dowgier, Giulia
    Penn, Rebecca
    Sanderson, Theo
    Stevenson-Leggett, Phoebe
    Bazire, James
    Harvey, Ruth
    Champsas, Dimitrios
    Aojula, Anuriti
    Bianchi, Alessia
    Al-Araji, Sarmad
    Hacohen, Yael
    Kassiotis, George
    Gamblin, Steve
    Lewis, Nicola
    Williams, Bryan
    Swanton, Charles
    Gandhi, Sonia
    Bauer, David
    Wu, Mary
    Carr, Edward
    Wall, Emma
    Ciccarelli, Olga
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 505 - 506
  • [30] Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
    Petereit, Hela-Felicitas
    Tumani, Hayrettin
    Zettl, Uwe K.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
12345